Research / SRXH / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-24-014436 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
13.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.05% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-29.40% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
17.13% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
30.57% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-54.88% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.26% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.59% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 16 states History building
Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/9 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 0/7 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 6/9 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Jun 30, 2025 5/5 normalized Level 3 Sep 30, 2025 5/5 normalized Level 3 Dec 31, 2025 5/5 normalized Level 3 Mar 31, 2026 5/5 normalized Level 3 Jun 30, 2026 4/5 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 38.12%
Current 13.71%
Delta -24.41% Capex Intensity Increased
Previous 0.00%
Current 0.05%
Delta 0.05% Cash Generation Decreased
Previous 2.61%
Current 0.25%
Delta -2.36% Growth Decreased
Previous 10.55%
Current -29.40%
Delta -39.95% Inventory Pressure Decreased
Previous 57.49%
Current 17.13%
Delta -40.36% Margin Decreased
Previous 33.82%
Current 30.57%
Delta -3.25% Profitability Decreased
Previous -19.94%
Current -54.88%
Delta -34.94% Sbc Intensity Increased
Previous 3.81%
Current 4.59%
Delta 0.78% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.